Speaker illustration

Doctor Alexander Christian Falkentoft

Zealand University Hospital, Roskilde (Denmark)

Member of:

European Society of Cardiology

Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: Anti-diabetic pharmacotherapy in clinical practice

Thumbnail

The impact of statins and RAS inhibitors on the association between delayed antidiabetic treatment and the risk of cardiovascular event in patients with a first HbA1c between 48-57 mmol/mol

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Diabetes and the heart 2

Thumbnail

Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study

Event: ESC Congress 2021 - The Digital Experience

Topic: Diabetes and the Heart

Session: Risk Factors and Prevention ePosters

Thumbnail

Socioeconomic position influences the risk of first-time cardiovascular event in patients with type 2 diabetes in spite of equal access to healthcare - a Danish nationwide cohort study

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology

Session: Cardiovascular Involvement in pre-Diabetes

Thumbnail

Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction

Event: ESC CONGRESS 2017

Topic: Biomarkers

Session: Adverse outcome in patients with cardiometabolic disorders

Thumbnail

ESC 365 is supported by

logo Novo Nordisk